BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25090092)

  • 1. Chondroitin sulfate-E is a negative regulator of a pro-tumorigenic Wnt/beta-catenin-Collagen 1 axis in breast cancer cells.
    Willis CM; Klüppel M
    PLoS One; 2014; 9(8):e103966. PubMed ID: 25090092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by chondroitin sulfate E can specify functional Wnt/β-catenin signaling thresholds in NIH3T3 fibroblasts.
    Willis CM; Klüppel M
    J Biol Chem; 2012 Oct; 287(44):37042-56. PubMed ID: 22915582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic role of chondroitin sulfate in cardiac differentiation of embryonic stem cells through inhibition of Wnt/β-catenin signaling.
    Prinz RD; Willis CM; van Kuppevelt TH; Klüppel M
    PLoS One; 2014; 9(3):e92381. PubMed ID: 24667694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling in triple negative breast cancer is associated with metastasis.
    Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
    BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling.
    Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE
    J Cancer Res Clin Oncol; 2015 Feb; 141(2):243-54. PubMed ID: 25209439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parsing β-catenin's cell adhesion and Wnt signaling functions in malignant mammary tumor progression.
    Buechel D; Sugiyama N; Rubinstein N; Saxena M; Kalathur RKR; Lüönd F; Vafaizadeh V; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34408016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
    Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
    J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondroitin sulfate-mediated N-cadherin/β-catenin signaling is associated with basal-like breast cancer cell invasion.
    Nadanaka S; Kinouchi H; Kitagawa H
    J Biol Chem; 2018 Jan; 293(2):444-465. PubMed ID: 29183998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide production upregulates Wnt/β-catenin signaling by inhibiting Dickkopf-1.
    Du Q; Zhang X; Liu Q; Zhang X; Bartels CE; Geller DA
    Cancer Res; 2013 Nov; 73(21):6526-37. PubMed ID: 24008318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells.
    Kim H; Seo EM; Sharma AR; Ganbold B; Park J; Sharma G; Kang YH; Song DK; Lee SS; Nam JS
    Int J Oncol; 2013 Oct; 43(4):1319-25. PubMed ID: 23900432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
    Johnson AL; Zinser GM; Waltz SE
    Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of fucosylated chondroitin sulfate from the sea cucumber Acaudina molpadioides on adipogenesis is dependent on Wnt/β-catenin pathway.
    Xu H; Wang J; Zhang X; Li Z; Wang Y; Xue C
    J Biosci Bioeng; 2015 Jan; 119(1):85-91. PubMed ID: 24982018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
    Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
    Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway.
    Saydam O; Shen Y; Würdinger T; Senol O; Boke E; James MF; Tannous BA; Stemmer-Rachamimov AO; Yi M; Stephens RM; Fraefel C; Gusella JF; Krichevsky AM; Breakefield XO
    Mol Cell Biol; 2009 Nov; 29(21):5923-40. PubMed ID: 19703993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation.
    Stigliano I; Puricelli L; Filmus J; Sogayar MC; Bal de Kier Joffé E; Peters MG
    Breast Cancer Res Treat; 2009 Mar; 114(2):251-62. PubMed ID: 18404367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
    Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
    Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
    Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration.
    Foldynová-Trantírková S; Sekyrová P; Tmejová K; Brumovská E; Bernatík O; Blankenfeldt W; Krejcí P; Kozubík A; Dolezal T; Trantírek L; Bryja V
    Breast Cancer Res; 2010; 12(3):R30. PubMed ID: 20507565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.